vimarsana.com

Fast Lab Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Brief This Week: Applied DNA Sciences, LumiraDx, Lucid Diagnostics, Nanomix, Strata Oncology

News items for the week of Aug. 15, 2022.

New yorkUnited statesStony brookBaton rougeSan leandroVidur sahneyFast lab solutionYork state department of healthZangmeister cancer centerBlood institute in hotSarah cannon research instituteNew york state departmentLinea monkeypox virusLuciddx labsWall streetChief operating officer

LumiraDx Inc: LumiraDx Reports Second Quarter 2022 Results

Strong Pipeline Progress and Commercialization Priorities for Newly Authorized ProductsLONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics

United kingdomCity ofRon zwanzigerColleen mcmillenExchange commissionFast lab solutionMovement in cashLumiradx limited nasdaqMelinda gates foundationStrong pipeline progressCommercialization prioritiesNewly authorizedUltra poolLumiradx chairmanQuarter financialLumiradx platform

Investegate |LumiraDx Inc Announcements | LumiraDx Inc: LumiraDx Reports Second Quarter 2022 Results

Investegate announcements from LumiraDx Inc, LumiraDx Reports Second Quarter 2022 Results

United kingdomCity ofRon zwanzigerColleen mcmillenExchange commissionFast lab solutionMovement in cashLumiradx limited nasdaqMelinda gates foundationLumiradx reports second quarterPipeline progressCommercialization prioritiesNewly authorizedUltra poolLumiradx chairmanQuarter financial

LumiraDx Reports Second Quarter 2022 Results

LONDON, Aug. 18, 2022 LumiraDx Limited , a next-generation point of care diagnostics company, today announced operational and financial results for the second quarter ended June 30,. | August 18, 2022

United kingdomCity ofRon zwanzigerColleen mcmillenExchange commissionFast lab solutionMovement in cashLumiradx limited nasdaqMelinda gates foundationUltra poolLumiradx chairmanQuarter financialLumiradx platformPrivate securities litigation reform actAnnual reportConsolidated statement

vimarsana © 2020. All Rights Reserved.